LXEO
Lexeo Therapeutics, Inc.
3.50$
-2.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 71.0% | 88.9% | 92.9% | 92.3% | 91.7% | 85.8% | 83.8% | 79.5% | 88.8% | 70.1% | 80.2% | 85.5% | |
| 64.8% | 86.9% | 91.5% | 91.1% | 90.3% | 23.8% | 23.0% | 20.2% | 28.5% | 23.4% | 28.7% | 36.4% | |
| 64.8% | 86.9% | 91.5% | 91.1% | 90.3% | 82.7% | 79.4% | 75.5% | 28.5% | 67.6% | 28.7% | 83.1% | |
| 397.5% | 18.8% | 14.2% | 14.1% | 19.9% | 20.5% | 29.9% | 21.5% | 16.0% | 8.2% | 7.5% | 7.8% | |
| 42.1% | 12.3% | 10.1% | 9.8% | 15.4% | 15.5% | 24.5% | 17.9% | 12.0% | 6.3% | 5.7% | 6.2% | |
| 12.3% | 1.9% | 1.2% | 1.4% | 1.5% | 1.8% | 2.1% | 1.5% | 1.9% | 1.0% | 1.1% | 1.0% | |
| 4.9% | 2.7% | 2.0% | 3.0% | 4.9% | 4.4% | 9.5% | 11.4% | 3.2% | 1.8% | 1.3% | 1.6% | |
| -297.5% | 81.2% | 85.8% | 85.9% | 80.1% | 79.5% | 70.1% | 78.5% | 84.0% | 91.8% | 92.5% | 92.2% | |
| -306.4% | -130.1% | -95.5% | -117.1% | -146.2% | -190.7% | -248.9% | -192.5% | -249.7% | -141.5% | -159.9% | -167.2% | |
| 46.0% | 19.5% | 13.1% | 17.2% | 19.0% | 22.5% | 26.3% | 24.7% | 42.4% | 28.4% | 32.4% | 33.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.